PubMed HealthSearch

PubMed · 8146437

Circadian rhythms.

Abstract

Changes in behavior which occur on a daily or circadian basis represent one of the most ubiquitous strategies by which most living organisms have adapted to their environment. Underlying the daily changes in behavior are a multitude of endocrine and metabolic rhythms which provide adaptively significant temporal organization within the organism. In mammals there appears to be a central circadian clock in the SCN which is responsible for generating and coordinating the entire 24-hour temporal organization of the animal. The circadian clock regulates the timing, duration, and characteristics of sleep, and together the circadian clock and sleep interact to control the timing of endocrine secretions. While the impact of disturbed endocrine circadian rhythms for the survival of the species has received very little attention, the almost universal presence of circadian rhythmicity within the endocrine system argues in support of the hypothesis that a disruption of the normal circadian organization within the endocrine system can have serious consequences for the health and well-being of the organism. It is particularly noteworthy that in advanced age, various alterations in circadian endocrine rhythms have been observed and these alterations may impair the ability of the animal to adapt normally to the environment. Relatively speaking, the study of circadian rhythms is a new field of biology, and as a result, much remains to be discovered about the physiological mechanisms that underlie rhythmicity, as well as the functional significance of 24-hour temporal organization for the survival of the species.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F W Turek. 1994. Circadian rhythms.. https://doi.org/10.1016/b978-0-12-571149-4.50007-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.

BACKGROUND: Oversecretion of corticotropin-releasing hormone and/or dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis may contribute to pathophysiologic processes in panic disorder, but documentation of HPA axis disturbance in panic has been inconsistent. In the current study we examined HPA axis activity in panic disorder over a full circadian cycle, using frequent blood sampling to provide detailed assessment of corticotropin and cortisol secretion. METHODS: Twenty patients with panic disorder and 12 normal control subjects were studied. Blood samples were drawn every 15 minutes for 24 hours and assayed for corticotropin and cortisol levels. RESULTS: Patients with panic disorder had elevated overnight cortisol secretion and greater amplitude of ultradian secretory episodes. Patients who entered the study through clinical referral channels had greater cortisol secretion than those recruited by advertisements. Patients with panic disorder who had a low frequency of panic attacks had elevated daytime corticotropin levels and elevated corticotropin ultradian amplitude. Patients with a high frequency of attacks had shifted corticotropin circadian cycles. CONCLUSIONS: Patients with panic disorder demonstrate subtle alterations in HPA axis activity, characterized by overnight hypercortisolemia and increased activity in ultradian secretory episodes, but HPA axis alterations in panic are modulated by illness severity and treatment seeking. It remains unclear whether HPA axis dysregulation in panic represents a pathogenic defect within the axis itself. Inconsistencies in prior work may reflect the subtlety of the abnormalities seen, differences in clinical characteristics of patients studied, and the use of different probes and measurement contexts.

Activity Cycles

Chronic lateral ventricle infusion of a pineal gland-derived decapeptide alters pulsatile secretion of LH in rats.

The object of this investigation was to determine whether chronic lateral ventricle infusion of a pineal gland-derived antigonadotropic decapeptide (AGD) would affect pulsatile luteinizing hormone (LH) release in conscious, unrestrained male rats. Adult male Harlan SD rats were bilaterally orchiectomized and maintained under conditions of controlled photoperiods and temperature. After three (Experiment one) or four (Experiment two) weeks each was fitted stereotaxically with a stainless steel cannula for infusion into the right lateral ventricle. Each cannula was attached to a subcutaneous osmotic minipump filled either with artificial cerebrospinal fluid (CSF) or AGD in CSF (0.5 microgram/microliter). CSF (1.0 microliter/hr) or the AGD (0.5 microgram/microliter hr) was infused over a period of four days. Blood samples for determined of LH by radioimmunoassay were obtained at five minute intervals from a Tygon microbore cannula inserted via a femoral artery into the abdominal aorta. LH pulses were defined and identified with a computerized deconvolution algorithm designed to determine spontaneous LH secretory events. Although mean LH levels were not significantly reduced, LH secretory pulse frequency and nadirs were significantly decreased by ADG infusion (p<0.01). Additionally, LH secretory pulse amplitude and LH secretory response to LHRL administration were significantly increased (p<0.01) by AGD treatment. These results confirm initial reports of depressive effects of the AGD on LH secretion and support its hypothesized central site of action.

Activity Cycles

National Cooperative Growth Study substudy. II: Do growth hormone levels from serial sampling add important diagnostic information?

The National Cooperative Growth Study includes growth data on more the 24,000 children in the United States and Canada who have been treated with growth hormone (GH). To determine whether dysregulation of GH release causes growth failure in children, we initiated the National Cooperative Growth Study substudy II to evaluate the diagnostic utility of serially sampled GH levels and to determine whether those patterns were responsible for the low growth rates in certain subsets of short children and whether children in any of the diagnostic categories would respond to GH therapy. A total of 3744 subjects whose mean height standardized for their chronological age was -2.8 SD and whose pretreatment growth rate was 4.2 cm/yr had complete 12-hour data sets-- serial samples obtained in a 12-hour overnight period. Pulsatile characteristics of GH release were assessed with the cluster algorithm. There was a virtually complete overlap of the GH pulsatile characteristics between control subjects and short children, but the insulin-like growth factor I (IGF-I) levels were markedly lower in the short children, suggesting impairment in the GH-IGF-I axis. THe growth response to administered GH showed only very weak correlations with the various cluster-derived parameters. Our results indicate that one must look beyond the release of GH to find an explanation for the short statures and low IGF-I levels in the subsets of children with idiopathic short stature.

Activity Cycles